Literature DB >> 23083519

Activation of the cholinergic anti-inflammatory system in peripheral blood mononuclear cells from patients with borderline personality disorder.

Marina Díaz-Marsá1, Karina S Macdowell, Itziar Guemes, Víctor Rubio, José L Carrasco, Juan C Leza.   

Abstract

A case-control study including patients (n = 20) with Borderline Personality Disorder (BPD) and healthy controls (n = 33) was carried out. To avoid interferences of other clinical conditions on biological findings, patients were free of current major depressive episodes or substance dependence disorders, and had no life history of schizophrenia, bipolar or neuropsychiatric disorders. Patients were free of medication for at least two weeks at the time of the study. Studies carried out in peripheral mononuclear blood cells and plasma evidence a systemic inflammatory condition in unstable-impulsive BPD patients. Specifically, a significant increase in some intracellular components of two main pro-inflammatory pathways such as iNOS and COX-2, as well as an increase in the plasma levels of the inflammatory cytokine IL1β. Interestingly, patients have an increase in the protein expression of the anti-inflammatory subtype of nicotinic receptor α7nAChR. This finding may reflect a possible mechanism trying to maintain intracellular inflammation pathways under control. All together, these results describe an imbalanced, pro-inflammatory and oxidant phenotype in BPD patients independent of plasma cotinine levels. Although more scientific evidence is needed, the determination of multiple components of pro- and anti-inflammatory cellular pathways have interesting potential as biological markers for BPD and other generalized impulsive syndromes, specially data obtained with α7nAChR and its lack of correlation with plasma levels of nicotine metabolites. Their pharmacological modulation with receptor modulators can be a promising therapeutic target to take into account in mental health conditions associated with inflammatory or oxido/nitrosative consequences. Also, identifying at-risk individuals would be of importance for early detection and intervention in adolescent subjects before they present severe behavioural problems.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083519     DOI: 10.1016/j.jpsychires.2012.09.009

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

1.  Inflammation and psychopathology: what we now know, and what we need to know.

Authors:  Monica Uddin; Vaibhav A Diwadkar
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-30       Impact factor: 4.328

Review 2.  Toward an animal model of borderline personality disorder.

Authors:  M B Corniquel; H W Koenigsberg; E Likhtik
Journal:  Psychopharmacology (Berl)       Date:  2019-06-15       Impact factor: 4.530

3.  Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression.

Authors:  Nunzio Pomara; Davide Bruno; Chelsea Reichert Plaska; Anilkumar Pillai; Jaime Ramos-Cejudo; Ricardo Osorio; Bruno P Imbimbo; Amanda Heslegrave; Henrik Zetterberg; Kaj Blennow
Journal:  J Affect Disord       Date:  2021-03-09       Impact factor: 4.839

4.  Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study.

Authors:  Mei-Ling Liu; Xiao-Tong Zhang; Xiang-Yu Du; Zheng Fang; Zhao Liu; Yi Xu; Peng Zheng; Xue-Jiao Xu; Peng-Fei Cheng; Ting Huang; Shun-Jie Bai; Li-Bo Zhao; Zhi-Guo Qi; Wei-Hua Shao; Peng Xie
Journal:  J Transl Med       Date:  2015-07-14       Impact factor: 5.531

5.  Reduced glucocorticoid receptor expression in blood mononuclear cells of patients with borderline personality disorder.

Authors:  José Manuel López-Villatoro; Karina S MacDowell; Marina Diaz-Marsá; Alejandro De La Torre-Luque; Clara Prittwitz; Alejandra Galvez-Merlin; Juan C Leza; Jose L Carrasco
Journal:  Front Psychiatry       Date:  2022-08-02       Impact factor: 5.435

6.  Consistency and coherence in treatment outcome measures for borderline personality disorder.

Authors:  Alok Madan; J Christopher Fowler
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2015-01-24

7.  Aberrant DNA Methylation of rDNA and PRIMA1 in Borderline Personality Disorder.

Authors:  Stefanie Teschler; Julia Gotthardt; Gerhard Dammann; Reinhard H Dammann
Journal:  Int J Mol Sci       Date:  2016-01-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.